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Abstract
Background: No data exist on the size of the population potentially in need of palliative care in Germany. The aim
of this study is to estimate the size of the German population that may benefit from palliative care.
Method: Based on existing population-based methods (Rosenwax and Murtagh), German death registration data
were analyzed and contrasted with international results. The data include all death cases in 2013 in Germany.
Results: According to the method Rosenwax defined, between 40.7 % (minimal estimate) and 96.1 % (maximal
estimate) of death cases could benefit from palliative care. The estimation, based on Murtagh’s refined method,
results in 78.0 % of death cases potentially being eligible for palliative care. The percentage of potential palliative
care candidates is conditioned by age. Based on the Murtagh Method, in the age category between 30 and
39 years, a potential demand for palliative care can be found for 40.4 % percent of all deaths occurring in this age
category, with this number increasing to 80.3 % in the age bracket of 80 years and over.
Conclusion: An estimation of the size of the population in need is essential for healthcare planning. Therefore, our
data serve as a guide and starting point for further research.
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Background
In an aging society, the burden of dealing with cancer
and other chronic life-threatening diseases increases. Ac-
cording to the WHO (World Health Organization), the
aim of palliative care, as an interdisciplinary profession,
is to provide symptom control and support for affected
patients and their families who are facing a terminal ill-
ness [1]. Palliative care has been established to focus on
relieving pain in cancer patients [2]. Until now, palliative
care has been centered around the treatment of cancer
patients [3, 4], although there has been increasing re-
search showing the demand for palliative care in chronic
non-cancer patients with a terminal diagnosis [5–7]. The
need for palliative care can be defined in many ways [8],
including using Bradshaw’s categories (felt, expressed,
normative, and comparative needs) [9]. The ability of pa-
tients to benefit from palliative care (normative perspec-
tive) seems to be a useful approach for defining need in
this context [10]. In Germany, the majority of patients in
palliative care services are cancer patients [3]. Because
terminally ill patients with cancer, as well as those with
non-cancer diagnoses, benefit from palliative care, it is
important to enable access for all patients that could
benefit from palliative care [5–7]. In order to provide
the needed care and to make adequate palliative care
services available, it is necessary to have data on the ac-
tual need for care. Regarding palliative care, there is a
distinction to be made between primary palliative care
provided by general practitioners, for example, or spe-
cialized palliative care supplied by physicians specializing
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in palliative care, for example in hospitals or ambulatory
teams [11].
Palliative care in Germany
Palliative care is an emerging medical field in Germany,
but compared to Great Britain, which is considered the
pioneer in the development of palliative care [12], more
action needs to be taken to catch up, even though
Germany is improving [13]. According to the Quality of
Death Index 2015, published by the Economist, Germany
ranks number 7 behind Great Britain (No. 1), Australia
(No. 2) and New Zealand (No. 3) [14]. Palliative care has
been stated to be a human right [15]. With the health-
care reforms in 2007 in Germany, every patient in need
of specialized palliative care should be able to receive
that care [16].
Population based methods to estimate need for
palliative care
Based on Western Australian death record data, Rosenwax
et al. [17] developed a method in 2005 to estimate the min-
imal, mid-range, and maximal numbers of people that
could potentially benefit from palliative care during
their last year of life based on administrative data.
For the minimal estimate, 10 medical conditions
(neoplasms, heart failure, renal failure, chronic obstructive
pulmonary disease, Alzheimer’s disease, liver failure,
Parkinson’s disease, motor neuron disease, Huntington’s
disease, and HIV/AIDS) were determined using focus
groups, interviews, and literature reviews, identifying af-
fected patients who could benefit from palliative care be-
fore death. The codes for these medical conditions are
used to identify the population of individuals that are po-
tentially in need for palliative care within death registra-
tion data. In other words, everybody who died because of
one of the defined conditions is classified as a palliative
care candidate. The mid-range estimate resulted from
matching death certificate data with hospital data, includ-
ing certain hospital admissions during the last year of life.
The maximal estimate is based on all deaths, exclud-
ing death during pregnancy, childbirth, or the puer-
perium, originating during the perinatal period, or
resulting from external causes, like injury or poison-
ing, as palliative care does not seem appropriate in
these populations [17].
Murtagh et al. refined this method in 2014 because,
according to the authors, the minimal method Rosenwax
et al. described underestimates the number of people
who may need palliative care. Additional diagnosis codes
were added and others were eliminated to account for
changes in diagnostic and treatment practices. Benign
neoplasms were excluded, and chronic heart diseases,
hypertensive and ischemic heart diseases, and cerebro-
vascular diseases were included. The categories of renal
and liver failures were extended to include chronic renal
and liver failures as well. Other chronic, respiratory, and
neurodegenerative diseases were included, like multiple
sclerosis and progressive supranuclear palsy. Addition-
ally, all types of dementia and Alzheimer’s diseases were
added to the Rosenwax classification [10].
The results of the Rosenwax method were contrasted
with the Murtagh method, based on deaths in England oc-
curring between 2006 and 2008. The comparison showed
an increase from 37 to 63 % for all cases of death that
were potentially in need of palliative care [10].
Objectives
In Germany, no comprehensive population study exists on
the demand for palliative care and its need within the
population. Therefore, the aim of our study was to obtain
a range of estimations to get a sense of how many people
may be in need of palliative care. These data can be seen
as baseline data for health system planning and are the
basis for further discussion about palliative care needs in
cancer and non-cancer patients. The current study was
based on Murtagh et al. and Rosenwax et al.’s methods.
The findings were then contrasted with international data.
Method
This study was based on three (Rosenwax’s minimal and
maximal estimations and Murtagh’s adapted version) of
the existing methods to estimate the number of people
who are possibly in need of palliative care. Data on the
number and causes of deaths were derived from death
registration data. This population-based database, pub-
lished annually by the Federal Bureau of Statistics, is a
complete inventory count of all cases of death in
Germany. It contains information on the cause of death,
as well as sex and age. The cause of death is coded using
the ICD-10-WHO code, making international compari-
sons possible [18]. Based on the death certificate, quali-
fied coders identify the underlying cause of death and
document the relevant code. According to the WHO,
the mortality statistics contain the main underlying
cause of death (monocausal) [19]. The mortality statistics
can be seen as secondary statistics and can be used for
epidemiological research, regional comparisons, and
health services research. As it is not possible in Germany
to match the mortality statistics with hospital admission
data, our analyses were restricted to the Rosenwax min-
imal and maximal estimate method [17] and the Murtagh
method [10], an adaption of the Rosenwax minimal esti-
mate method, performed by Murtagh et al. The database
used for our calculation is the German Mortality Statistics
2013, as it is the latest data year available at this point.
To transfer the Rosenwax (Australia) and Murtagh
(Great Britain) methods to German data, some adaptions
had to be made to convert the defined codes to ICD-10-
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WHO year 2013 codes. This has been necessary, as the
ICD-Codes between countries and years can differ (See
Table 1 for the utilized ICD-10-WHO year 2013 codes).
To apply the Rosenwax method to German data, the
ICD-10-AM codes had to be converted to ICD-10-
WHO codes. The ICD-codes our analyses are based on
can be found in Table 1.
The maximal estimate codes, defined by Rosenwax et
al. and used by Murtagh et al., were converted into ICD-
10-WHO codes that did not need any adaptions. The
maximal estimate includes all deaths except those due to
one of the following conditions:
 Pregnancy, childbirth, or puerperium (ICD-10-WHO
codes O00–O99)
 Those originating during the perinatal period
(ICD-10-WHO codes P00–P96)
 Injury, poisoning, and other similar causes (ICD-10-
WHO codes S00–T98)
 External causes (ICD-10-WHO codes V01–Y98)
The database provided by the Federal Bureau of Statis-
tics contains no data on the personal level, and is there-
fore open to the public. Thus, obtaining ethical approval
is not necessary.
Results
A total of 893,825 people died in Germany in 2013, with
the majority dying from diseases of the circulatory sys-
tem (39.7 %), followed by neoplasms (25.0 %). According
to the Rosenwax method, a total of 363,689 (40.7 %)
deaths were potentially in need of palliative care in
Germany in 2013. Neoplasms accounted for 63.5 % of all
deaths with regard to all potential palliative care candi-
dates identified using the Rosenwax method.
Using the Murtagh method, the number of people
who could benefit from palliative care was 697,281
(78.0 %), which is almost twice as many people com-
pared to the Rosenwax method. The largest deviation
between the Murtagh and Rosenwax methods could be
found within the category “heart,” where almost 60.0 %
Table 1 Comparison of the Rosenwax and Murtagh methods for estimating the need for palliative care
Rosenwax Method n Murtagh Method n Difference
Neoplasm C00–D48 230.840 (25.82 %) Malignant
neoplasm
C00–C97 223.842 (25.04 %) 6.998
Cancer (breast) C50 18.009 (2.01 %)
Cancer (colorectal) C18–C21 25.693 (2.87 %)
Cancer (lung) C30–C39 46.896 (5.25 %)
Cancer (prostate) C61 13.408 (1.5 %)




74.704 (8.36 %) Heart disease
(chronic)
I00–I52 274.821 (30.75 %) 258.673
Cerebrovascular
disease (stroke)
I60–I69 58.556 (6.55 %)
Renal failure N10, N11, N18,
N120, N131, N132





18.817 (2.11 %) 10.229
Liver failure K704, K711, K721,
K729





31.570 (3.53 %) Respiratory disease J06–J18, J20–J22,
J40–J47 & J96
55.557 (6.22 %) 23.987
Neurodegenerative
disease




12.349 (1.38 %) 1.508
Huntington’s disease G10 332 (0.04 %)
Motor neuron disease G122 1.878 (0.21 %)
Parkinson’s disease G20 8.631 (0.97 %)
Alzheimer’s disease G300, G301, G308,
G309
6.252 (0.70 %) Dementia,
Alzheimer’s, senility
F01, F03, G30, R54 37.683 (4.22 %) 31.431
HIV/AIDS B20–B24 401 (0.04 %) HIV/AIDS B20–B24 401 (0.045 %) 0
Total deaths from
these conditions
363.689 40.7 % of all
deaths (n = 893.825)
Total deaths from
these conditions
697.281 78.0 % of all
deaths (n = 893.825)
A transformation of the Rosenwax ICD-10-AM to ICD-10-WHO codes was not possible for codes I111, N102, and N112. Hence, we replaced these codes with codes
I11.0, I11.9, N10, N11.1, N11.8, and N11.9 ICD-10-WHO
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of the deviation can be explained. The proportion of pa-
tients in need of palliative care because of a heart disease
rises from 8.4 % (Rosenwax) to 30.8 % (Murtagh), mak-
ing heart disease the most frequent underlying cause for
the potential demand of palliative care.
According to the maximal estimate originally developed
by Rosenwax et al. [17], a total of 858,546 people, account-
ing for 96.1 % of all deaths, could be potential palliative
care patients. The Rosenwax minimal method identifies
40.7 % of all deaths eligible for palliative care, and Mur-
tagh’s adaption of the Rosenwax method for a minimal es-
timate expands the demand to 78.0 % of all deaths (Fig. 1).
To give further insight into age-related differences re-
garding the demand for palliative care, we performed an
additional analysis accounting for the factor "age". We
estimated the demand for palliative care within the dif-
ferent age groups with the Murtagh method and the
maximal estimate (Rosenwax method). The results
showed that, according to Murtagh, the demand in chil-
dren aged 0 to 9 years lies at 9.9 % of all deaths occur-
ring in this age category. The percentage of potential
palliative care candidates rises to 40.4 % in the age cat-
egory between 30 and 39 years and keeps increasing to
80.3 % in people aged 80 and over. Similar results, but
on a higher level (10–15 percentage points higher than
the Murtagh method), can be found for the maximal es-
timate, with the biggest discrepancies within the age cat-
egory 0 to 9 years (almost 25 percentage points higher).
The increase of potential palliative care needs with older age
is caused by a change of the cause of death from more exter-
nal causes of death, like accidents, to more cases of death
caused by diseases, potentially creating a need for palliative
care (e.g. cancer and vascular diseases) (Figs. 2 and 3).
Discussion
Comparing the need for palliative care in the German
population, we can find similar results to those from
Western Australia and Great Britain. By using the
Rosenwax method, we identified 40.7 % of all deaths oc-
curring in Germany in 2013 as being caused by condi-
tions Rosenwax et al. defined. Murtagh et al. found
similar results for England, indicating that 37 % of all
deaths may have been preceded by a need for palliative
care [10]. The percentage, according Rosenwax et al.’s
minimal estimate, is 50 % of all deaths for Western
Australia [17]. Worldwide, the percentage ranges from be-
tween 25 % (Mexico) and 49 % (Netherlands), whereas in
Western Europe (excluding Germany), the lowest rate lies
at 41 % (Wales) [20]. Murtagh et al. adapted Rosenwax’s
minimal estimate method by adding extra conditions that,
in the opinion of questioned experts, palliative care
seemed to be appropriate for. Other conditions where pal-
liative care did not seem appropriate were deleted [10].
For England, an estimated 63 % of all deaths fall in the
categories defined by Murtagh et al [10]. By using the
Murtagh method, 78 % of all deaths in Germany would
potentially be in need of palliative care. This percentage is
substantially higher than the findings from England. Here,
the highest discrepancy was found with regard to coded
deaths due to heart disease. In Germany in 2013, the
underlying cause of death was a heart disease in approxi-
mately 31 % of all cases, whereas in England, only about
12 % of all deaths were caused by heart disease [10]. Com-
paring our data to mortality data from the WHO in 2013,
Germany has an age-standardized death rate for diseases
of the circulatory system of 145.5 per 100,000, compared
to the United Kingdom (104.3) or the United States
(131.2) [21]. In addition to the higher mean age of the
German population, differences in the population’s spe-
cific death rate for the circulatory system could partly ex-
plain the discrepancies found. Comparing the need for
palliative care with data from Australia [17] and Great
Britain [10] for people dying at an age over 65, Germany












Rosenwax et al. Murtagh et al. maximal estimate
not in need
potentially in need
Fig. 1 Percentage of death cases classified as potentially in need vs. not in need
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in this age group. In Germany, people dying over the
age of 65 account for 84.4 % of all death cases, while
in Western Australia only 77.0 % of deaths occur
over the age of 65 [17].
With a median age of 46.5 years, Germany is the sec-
ond oldest nation worldwide, with only Japan having a
higher median age [22]. With older age, more and more
people die from conditions potentially generating a need
for palliative care; therefore, in an aging society, a higher
demand for palliative care can be assumed.
The need for palliative care has to be seen alongside
with the supply of palliative care in the corresponding
country. Prior estimations for Germany stated a demand
of 80 to 100 hospital beds (hospice and palliative care)
per million inhabitants [13]. Inpatient palliative care is
one of many ways to deliver palliative care. As the ma-
jority of Germans with terminal diseases wish to die at
home [23], there is a need to provide palliative care at
home. Because patients benefit from early access to pal-
liative care [24, 25] and costs can be cut [26], it is im-
portant to implement palliative care early in care
trajectories, making the demand for palliative care even
higher, as the utilization is not restricted to the time
shortly before death. Until now, it was mainly pa-
tients with cancer who received palliative care in
Germany [27], although many terminally ill patients
with a non-cancer disease benefit from palliative care
as well [5–7].
Limitations
The Rosenwax and the Murtagh methods are based on
death certificate data. The limitations of the Rosenwax and
Murtagh methods have been widely discussed [10, 17, 28];
therefore, at this point, we only want to give a short sum-
mary of the main limitations. Both measures are based on
death certificate data, whereby some diagnoses (e.g. demen-
tia, Parkinson’s or renal diseases) may be under-recorded
[10], especially when only the underlying cause of death
has been documented. Population-based measures, like
the ones Rosenwax and Murtagh utilized are condition-
based and are therefore not able to measure the patients’
actual needs for palliative care [10, 17, 28], as need is de-
termined by many factors, in addition to the diagnosis
alone [29, 30]. Severity, in addition to illness trajectories,
is not accounted for. This may be especially relevant when
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Fig. 3 Demand for palliative care in death cases > 65 years of age incomparison to Rosenwax and Murtagh
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there can be a possible demand for palliative care over the
course of years [10]. These estimations on a population
basis can be seen as a low-cost, pragmatic approach for
policy and resource allocation, including a certain degree
of misclassification [28].
If further data are available, other methods do exist to
perform estimations on the realistic need for palliative
care in a population. For example, Gómez-Batiste et al.
performed an analysis based on the prevalence of symp-
toms, chronic conditions, and structural information re-
garding the rate of home residences [31]. Rosenwax et
al. performed further estimations by linking hospital ad-
mission data to get a mid-range estimate, including all
deaths with a hospitalization record one year prior to
death because of the same condition that was docu-
mented in the death certificate [17]. As it is not possible
to link further data to this nationwide German dataset,
our results serve as a rough estimation of the palliative
care needs in Germany. Further studies, based on health
insurance companies’ data, could provide further informa-
tion, although these results can lack generalizability. Our
study is based on data of one single year (2013). Further
findings can be obtained using a longitudinal analysis and
expansion of the databases to more than one analyzed
year.
Conclusion
These figures (i.e. the amount of non-cancer patients who
could benefit from palliative care) can provide clues to
guide the future planning of palliative care service delivery
for patients with non-cancer diseases – particularly since
there is evidence of shortcomings in the provision of pal-
liative care for non-cancer patients in Germany [7].
From 2009 to 2050, the number of deaths in Germany
is expected to rise by 25 %, with a total increase of death
cases and more people dying at an advanced age. With a
higher need for palliative care at an older age, palliative
care becomes more and more important [32].
After all, "the demand for palliative care" cannot be
seen as a given fact, but is partly subject to continuously
evolving ideas of what is appropriate care, economic re-
sources and resource allocation. The estimates per-
formed can serve as a rough approximation, highlighting
the immense need for palliative care in an aging society
like Germany.
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